Pages that link to "Item:Q1661641"
From MaRDI portal
The following pages link to Mathematical modelling of enfuvirtide and protease inhibitors as combination therapy for HIV (Q1661641):
Displaying 12 items.
- Modelling two different therapy strategies for drug T-20 on HIV-1 patients (Q536537) (← links)
- Two-way Bayesian hierarchical phylogenetic models: an application to the co-evolution of gp120 and gp41 during and after enfuvirtide treatment (Q961188) (← links)
- Mechanism-based model of the pharmacokinetics of enfuvirtide, an HIV fusion inhibitor (Q1788684) (← links)
- Mathematical modeling for the prevention of methanol poisoning through ethanol by impulsive way (Q2020162) (← links)
- Modelling the effects of adherence to the HIV fusion inhibitor enfuvirtide (Q2632060) (← links)
- Impact of Tenofovir gel as a PrEP on HIV infection: a mathematical model (Q2632627) (← links)
- Impact of combined therapy in HIV-1 treatment: a double impulsive approach (Q2657593) (← links)
- Role of antibiotic therapy in bacterial disease: A mathematical study (Q4636789) (← links)
- The Impact of Vaccination to Control Human Papillomavirus Dynamics (Q4686753) (← links)
- MODELING MONOCYTE-DERIVED DENDRITIC CELLS AS A THERAPEUTIC VACCINE AGAINST HIV (Q4967054) (← links)
- Analysis of HIV latent infection model with multiple infection stages and different drug classes (Q5052707) (← links)
- How can HPV-induced cervical cancer be controlled by a combination of drug therapy? A mathematical study (Q5193359) (← links)
